Algae Dynamics Corp. (OTC: ADYNF), a company engaged in developing unique health products and pharmaceuticals utilizing cannabis and algae oils, is well-positioned to benefit from the impending legalization of recreational marijuana in Canada, which the Canadian government is endeavoring to accomplish by mid-2018.
Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today is pleased to announce that the Company will be launching its proprietary and patent-pending live plant transporter, the Aurora Envoy™.
The Green Organic Dutchman Holdings Ltd. announced it will increase its previously announced brokered unit offering and non-brokered offering of 12,121,500 Units of the Company for aggregate gross cash proceeds of C$20,000,475. The Company will issue an additional 6,060,700 Units of the Company at $1.65 for aggregate gross cash proceeds of C$30,000,630.
Bank of Montreal and Toronto-Dominion Bank are emerging as the banks of choice for Canada’s burgeoning marijuana industry, even as some lenders shun the sector.
Twelve of Canada's leading Licenced Producers of medical cannabis (including ABcann) today announced the creation of the Canadian Cannabis Co-op. The Co-op is prepared to make a significant investment in Alberta to create a turn-key retail solution to address the challenges of safe, regulated supply and socially-responsible cannabis retailing.
Justice Minister Kathleen Ganley unveils draft framework for marijuana legalization in Alberta
PotNetwork Holding, Inc. (OTC: POTN) this morning announced, as part of its strategy to formulate, produce and market a spectrum of exclusive and diversely targeted cannabidiol blends, its appointment of Richard Goulding, MD as its new chief executive officer.
Premier John Horgan has hinted again that British Columbia's growing number of illegal marijuana dispensaries could have a role to play when recreational use of the drug is made legal next summer.
India Globalization Capital, Inc. (NYSE American: IGC) this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at varying concentrations of IGC-AD1, mitochondrial function is enhanced by 30-60 percent.
The medical cannabis business is booming in Canada, projected to ramp up and exceed $8 billion within seven years. The growth trajectory shows no signs of slowing yet pales in comparison to the global opportunity.
Supreme Pharmaceuticals Inc. (TSXV: FIRE) announces that 7ACRES' first month of sales exceeded $1,500,000, and that such sales will be recorded in the quarter ended September 30, 2017.
The Canadian government's plan to push through legalization of marijuana for recreational purposes by mid-2018 figures to deal a serious blow to the existing black market. ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is poised to capitalize.
In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed relief to Alzheimer’s sufferers.
Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that its MoneyTrac Technology, Inc. subsidiary has completed the execution of a joint venture partnership agreement with MediaTechnics Corporation’s (OTC: MEDT) BlazeNow Inc. subsidiary.
InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has more major news today as they have filed a provisional patent for pain program. This is a huge step in protecting intellectual and commercial property related to their groundbreaking research into the potential of non-THC cannabinoids to treat pain using a topical formulation..
